Clinical Trials Browser

NCT06263088 2026-05-22

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

Anus Neoplasms, Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Neuroendocrine Tumors

NCT07377487 2026-05-22

INDIGO

Phase NA Recruiting

51 enrolled

EndocrineGastrointestinalNET

Carcinoma, Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Colorectal Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT06735560 2026-05-13

ELEGANCE

Phase NA Recruiting

60 enrolled

EndocrineGastrointestinalNET

Cirrhosis, Familial, with Pulmonary Hypertension, Carcinoma, Hepatocellular, Cholangiocarcinoma, Neuroendocrine Tumors

Clinical Trials

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

INDIGO

ELEGANCE

Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Pancreatic Neuroendocrine Tumors

Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

BCB RIV

Modified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm

Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

SMILE

Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors

MGMT-NET

LUTIBI

OPERANDI-NET

A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072

Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies

TNE-IDC-COLE

Trinav

GENEBIOLuNET

TARGETMONITO

Exploratory Study on the Efficacy of Betaine Hydrochloride in Treating Autoimmune Gastritis

Endoscopic Resection for Small Rectal Neuroendocrine Tumors

Dual-Tracer Theranostic PET

Liquid-NET

VISIONARY

DNET

Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients

DIB-NET

In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor

WIN

WIN

DIVIT-pilot

DIVIT Study Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor

NETest_Sx

Early Identification of Cardiac Involvement in Patients With Carcinoid: Clinical and Prognostic Implications

RAPNEN

68Ga-DOTATATE PET for Management of Neuroendocrine Tumors

Real-world Study on Adjuvant Octreotide Therapy in pNETs

Cryoablation of Bone Metastases From Endocrine Tumors

Radio-Marker

ERFA-PNET

Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers

Endoscopic Resection for Small Rectal Neuroendocrine Tumors

A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)

Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors

68-DOTANOC-GEP

Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency

FENET-2016

A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors